Article Text

PDF
Topical brinzolamide and metabolic acidosis
  1. G J Menon,
  2. S A Vernon
  1. Department of Ophthalmology, Eye and ENT Centre, University Hospital Nottingham, UK
  1. Correspondence to: Mr S A Vernon Department of Ophthalmology, Eye and ENT Centre, University Hospital Nottingham, Nottingham NG7 2UH, UK; stephen.vernon{at}qmc.nhs.uk

Statistics from Altmetric.com

Treatment of ophthalmic disease largely involves the administration of topical medication in doses that would appear small relative to those used systemically. With a few exceptions (such as β receptor antagonists) the systemic side effects of topical ocular medication, though recognised, are often ignored in clinical practice. We report a case that highlights the need for constant vigilance in the context of such ophthalmic therapy.

Case report

A 66 year old white man, on treatment with topical latanoprost for primary open angle glaucoma, required further reduction of intraocular pressure, in the pursuit of which topical brinzolamide was added to one eye only.

At review 3 months later, the patient reported having …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.